Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Operations (2021 - 2025)

Biote has reported Cash from Operations over the past 5 years, most recently at 7569000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 7569000.0 for Q4 2025, down 38.8% from a year ago — trailing twelve months through Dec 2025 was 35194000.0 (down 22.21% YoY), and the annual figure for FY2025 was 35194000.0, down 22.21%.
  • Cash from Operations for Q4 2025 was 7569000.0 at Biote, down from 14072000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for BTMD hit a ceiling of 17944996.0 in Q2 2021 and a floor of 28570000.0 in Q2 2022.
  • Median Cash from Operations over the past 5 years was 7027500.0 (2022), compared with a mean of 6594150.0.
  • Biggest five-year swings in Cash from Operations: tumbled 259.21% in 2022 and later soared 9622.5% in 2024.
  • Biote's Cash from Operations stood at 10080000.0 in 2021, then crashed by 39.97% to 6051000.0 in 2022, then grew by 14.96% to 6956000.0 in 2023, then soared by 77.8% to 12368000.0 in 2024, then crashed by 38.8% to 7569000.0 in 2025.
  • The last three reported values for Cash from Operations were 7569000.0 (Q4 2025), 14072000.0 (Q3 2025), and 7086000.0 (Q2 2025) per Business Quant data.